While Elanco Animal Health Inc has underperformed by -1.01%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ELAN fell by -23.62%, with highs and lows ranging from $18.80 to $11.40, whereas the simple moving average fell by -17.59% in the last 200 days.
On December 09, 2024, UBS started tracking Elanco Animal Health Inc (NYSE: ELAN) recommending Buy. A report published by Leerink Partners on December 02, 2024, Initiated its previous ‘Market Perform’ rating for ELAN. Morgan Stanley also Downgraded ELAN shares as ‘Equal-Weight’, setting a target price of $15 on the company’s shares in a report dated September 19, 2024. Stifel January 05, 2024d the rating to Buy on January 05, 2024, and set its price target from $13 to $20. Jefferies initiated its ‘Buy’ rating for ELAN, as published in its report on December 19, 2023. Morgan Stanley’s report from December 15, 2023 suggests a price prediction of $16 for ELAN shares, giving the stock a ‘Overweight’ rating. Exane BNP Paribas also rated the stock as ‘Outperform’.
Analysis of Elanco Animal Health Inc (ELAN)
Further, the quarter-over-quarter decrease in sales is -3.56%, showing a negative trend in the upcoming months.
There are several well-rounded types of analysis and research techniques that can be used to gain a clear view of Elanco Animal Health Inc’s future performance, with equity being one of the most critical indicators. The goal here is to ensure that your current return on equity of 3.24% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.31, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
As an indicator of volatility for any stock, average volume can also be very valuable, and ELAN is recording an average volume of 4.44M. On a monthly basis, the volatility of the stock is set at 3.55%, whereas on a weekly basis, it is put at 3.34%, with a loss of -0.17% over the past seven days. Furthermore, long-term investors anticipate a median target price of $17.92, showing growth from the present price of $11.80, which can serve as yet another indication of whether ELAN is worth investing in or should be passed over.
How Do You Analyze Elanco Animal Health Inc Shares?
Elanco Animal Health Inc (ELAN) is based in the USA and is one of the most prominent companies operating in the Drug Manufacturers – Specialty & Generic market. When comparing Elanco Animal Health Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 28.88, there is a growth in quarterly earnings of 132.88%.
Apart from looking at the fundamentals, you should also pay attention to the number of company employees who own shares. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 1.49%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 98.19% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
ELAN shares are owned by institutional investors to the tune of 98.19% at present.
